In the News

European Pharmaceutical Review: Anatomy of a ‘correlate of protection’ for T-cell vaccines

16 June 2022

Access the journal

NanoPass’s intradermal delivery platform used in Gylden’s next generation COVID-19 vaccination study

26 January 2022

As Covid mutates, the vaccine makers are adapting too

11 December 2021

UK firm to trial T-cell Covid vaccine that could give longer immunity

15 November 2021

Covid live: Egypt starts vaccine trial; Austria to put unvaccinated people in lockdown

14 November 2021

CNBC news interview with Gylden Vaccines CEO, Professor Thomas Rademacher

14 May 2018